Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
This paper reports the case of a 64-year-old man who was receiving parenteral nutrition after repeated operations due to stomach cancer. Olanzapine (orally disintegrating tablets) in combination with alprazolam was used successfully to relieve this terminally ill patient's anxiety and tension improving his relationship with his physicians and his daily life.
Douzenis
A
A
Department of General Hospital Psychiatry, Athens University Medical School, Attikon Hospital, Athens, Greece. panpsyclin@attikonhospital.gr
Michopoulos
I
I
Economopoulos
T
T
Lykouras
L
L
Soldatos
C R
CR
D000286:Administration, Sublingual; D000525:Alprazolam / Q000008:administration & dosage*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001569:Benzodiazepines / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010288:Parenteral Nutrition; D011369:Professional-Patient Relations; D011788:Quality of Life; D013274:Stomach Neoplasms / Q000523:psychology* / Q000601:surgery; D019452:Terminally Ill
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D000077152:Olanzapine; D000525:Alprazolam